Adrenergic Receptor Inhibitors
Adrenergic receptor inhibitors are pharmacological agents that block or inhibit the action of catecholamines such as adrenaline (epinephrine) and noradrenaline (norepinephrine) at their receptor sites in the central and peripheral nervous systems. Adrenergic receptors are divided into several subtypes, including alpha-adrenergic receptors (α1 and α2) and beta-adrenergic receptors (β1, β2, and β3), each playing distinct roles in regulating cardiovascular function, smooth muscle contraction, metabolic processes, and neurotransmission. Inhibitors bind to these receptors and prevent catecholamines from binding and exerting their effects, thereby reducing adrenergic-mediated responses. For example, beta-blockers like propranolol and metoprolol are beta-adrenergic receptor inhibitors commonly used to treat hypertension, angina, and arrhythmias by blocking beta receptors in the heart and blood vessels, leading to decreased heart rate, blood pressure, and myocardial oxygen demand. Alpha-blockers such as prazosin and doxazosin inhibit alpha-adrenergic receptors to relax smooth muscles in blood vessels and reduce blood pressure.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:3 Page 1 of 1 1
